Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism

ClinicalTrials.gov ID: NCT00062803

Public ClinicalTrials.gov record NCT00062803. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 1:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Van Gogh-PE Trial, a Multicenter, International, Randomized, Open-Label, Assessor-Blind, Non-Inferiority Study Comparing the Efficacy and Safety of Once-Weekly Subcutaneous SR34006 With the Combination of (LMW)Heparin and Vitamin K Antagonist (VKA) in the Treatment of Acute Symptomatic Pulmonary Embolism

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Patients who have a pulmonary embolism (blood clot in the lung) will be treated in this study. The purpose of the study is to compare the safety and effectiveness of a new injectable anticoagulant (blood-thinning) drug, SR34006, with the standard way of treating a pulmonary embolism. The standard treatment includes injections or infusions of an anticoagulant drug, (LMW)heparin, for about a week followed by anticoagulant tablets (warfarin or acenocoumarol) which are taken by mouth. Assignment to either SR34006 or (LMW)heparin plus warfarin or acenocoumarol will be purely by chance and will be known by both patients and their doctors.

Study identification

NCT ID
NCT00062803
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2003 (Type not available)
Primary completion
Oct 2005 (Actual)
Completion
Oct 2005 (Actual)
Last update posted
Apr 29, 2009

2003 – 2005

United States locations

U.S. sites
54
U.S. states
23
U.S. cities
46
Facility City State ZIP Site status
Jerry L. Pettic VA Medical Center Loma Linda California — —
University of California, San Diego Medical Center San Diego California — —
Anschutz Cancer Pavilion Aurora Colorado — —
University of Colorado Hospital Denver Colorado — —
Bay Pines VA Medical Center Bay Pines Florida 33744 —
Brandon Regional Hospital Brandon Florida 33511 —
Holmes Regional Medical Center Melbourne Florida 32901 —
Jackson Memorial Hospital Miami Florida 33136 —
St. Joseph's Hospital Tampa Florida 33607 —
Medical College of Georgia Augusta Georgia 30912 —
DeKalb Medical Center Decatur Georgia 30033 —
Loyola University Medical Center and Outpatient Clinic Maywood Illinois 60153 —
Olathe Medical Center Olathe Kansas — —
Christus St. Patrick Hospital Lake Charles Louisiana 70601 —
Sinai Hospital of Baltimore Baltimore Maryland — —
Boston Medical Center Boston Massachusetts — —
Baystate Medical Center Springfield Massachusetts 01199 —
Henry Ford Hospital Detroit Michigan 48202 —
St. Joseph Mercy - Oakland Pontiac Michigan 48341 —
William Beaumont Hospital Royal Oak Michigan 48073 —
William Beaumont Hospital Troy Michigan 48085 —
Lovelace Health Systems, Clinical Thrombosis Center Albuquerque New Mexico 87108 —
Winthrop Pulmonary Associates Mineola New York 11501 —
Winthrop University Hospital Mineola New York 11501 —
Mount Sinai School of Medicine New York New York — —
St. Luke's-Roosevelt Hospital Center New York New York — —
University of North Carolina Hospitals Chapel Hill North Carolina 27599 —
Altru Health System Hospital Grand Forks North Dakota 58201 —
Akron General Medical Center Akron Ohio 44307 —
Riverside Methodist Hospital Columbus Ohio 43214 —
Medical College of Ohio Toledo Ohio 43614 —
Saint Anthony Hospital Oklahoma City Oklahoma 73101 —
Oklahoma City VA Medical Center Oklahoma City Oklahoma 73104 —
OU Medical Center Oklahoma City Oklahoma 73104 —
INTEGRIS Southwest Medical Center Oklahoma City Oklahoma 73109 —
Lehigh Valley Hospital Allentown Pennsylvania 18105 —
Crozer-Chester Medical Center Upland Pennsylvania 19013 —
Spartanburg Regional Medical Center Spartanburg South Carolina 23903 —
Mary Black Memorial Hospital Spartanburg South Carolina 29307 —
Baptist Memorial Hospital Memphis Memphis Tennessee — —
The West Cancer Clinic Memphis Tennessee — —
Northwest Texas Healthcare System Amarillo Texas 79106 —
The Methodist Hospital Houston Texas 77030 —
Scott & White Memorial Hospital & Clinic Temple Texas 76508 —
The University of Texas Health Center at Tyler Tyler Texas 75708 —
University Hospital Salt Lake City Utah — —
Inova Alexandria Hospital Alexandria Virginia 22304 —
MedSource, Inc. Chesapeake Virginia — —
Portsmouth Pulmonary Associates Chesapeake Virginia — —
Pulmonary Associates of Fredericksburg, Inc. Fredericksburg Virginia — —
Maryview Medical Center Portsmouth Virginia — —
McGuire VA Medical Center Richmond Virginia 23249 —
Swedish Medical Center Seattle Washington 98122 —
Sacred Heart Medical Center Spokane Washington 99220 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00062803, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2009 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00062803 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →